ALVOTECH SDB revenue breakdown overview

ALVOTECH SDB revenue for the last year amounted to 5.47 B SEK, the most of which — 5.44 B SEK — came from its highest performing source at the moment, Biosimilar Medicines, the year earlier bringing 926.38 M SEK. The greatest contribution to the revenue figure was made by United States — last year it brought ALVOTECH SDB 3.03 B SEK.